Cargando…
Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346988/ https://www.ncbi.nlm.nih.gov/pubmed/32638568 http://dx.doi.org/10.4168/aair.2020.12.5.894 |
| _version_ | 1783556506790133760 |
|---|---|
| author | Kim, Ji Hye Park, Hae-Sim Ye, Young-Min Shin, Yoo Seob Kang, Hye-Ryun Chung, Soo Jie Choi, Jeong-Hee |
| author_facet | Kim, Ji Hye Park, Hae-Sim Ye, Young-Min Shin, Yoo Seob Kang, Hye-Ryun Chung, Soo Jie Choi, Jeong-Hee |
| author_sort | Kim, Ji Hye |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7346988 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73469882020-09-01 Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea Kim, Ji Hye Park, Hae-Sim Ye, Young-Min Shin, Yoo Seob Kang, Hye-Ryun Chung, Soo Jie Choi, Jeong-Hee Allergy Asthma Immunol Res Letter to the Editor The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2020-05-11 /pmc/articles/PMC7346988/ /pubmed/32638568 http://dx.doi.org/10.4168/aair.2020.12.5.894 Text en Copyright © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Kim, Ji Hye Park, Hae-Sim Ye, Young-Min Shin, Yoo Seob Kang, Hye-Ryun Chung, Soo Jie Choi, Jeong-Hee Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title_full | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title_fullStr | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title_full_unstemmed | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title_short | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea |
| title_sort | omalizumab treatment in patients with cholinergic urticaria: a real-world retrospective study in korea |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346988/ https://www.ncbi.nlm.nih.gov/pubmed/32638568 http://dx.doi.org/10.4168/aair.2020.12.5.894 |
| work_keys_str_mv | AT kimjihye omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT parkhaesim omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT yeyoungmin omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT shinyooseob omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT kanghyeryun omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT chungsoojie omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea AT choijeonghee omalizumabtreatmentinpatientswithcholinergicurticariaarealworldretrospectivestudyinkorea |